China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.850
-0.010 (-0.21%)
Jul 31, 2026, 4:08 PM HKT

HKG:3320 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
269,574269,574257,673244,704218,183192,920
Revenue Growth
3.31%4.62%5.30%12.16%13.10%14.31%
Gross Profit
44,50844,50840,68938,33733,61928,823
Operating Income
12,65112,65111,98411,0319,7418,019
Net Income
4,0424,0423,3313,8543,5003,070
Earnings Per Share
0.640.640.530.610.560.49
EPS Growth
44.37%21.34%-13.57%10.11%14.00%10.60%

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Elimination of Inter-Segment Sales
-13,848-13,848-12,066-10,570-8,891-7,090
Others
93.2593.2573.5876.3635.02133.55
Manufacturing
51,03951,03946,32443,46538,03431,458
Retail
12,21012,21010,1049,5797,5886,196
Distribution
220,080220,080213,237202,153181,418162,222
Total
269,574269,574257,673244,704218,183192,920

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
27,91327,91325,64832,23122,73124,034
Total Debt
72,77072,77069,00562,16156,41655,362
Net Cash (Debt)
-44,857-44,857-43,357-29,930-33,685-31,328
Net Cash Growth
------
Net Cash Per Share
-7.14-7.14-6.90-4.76-5.36-4.99

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
20,47620,47617,53615,55010,82110,462
Capital Expenditures
-2,331-2,331-2,645-2,523-2,279-1,967
Free Cash Flow
18,14618,14614,89113,0278,5428,495
Free Cash Flow Growth
5.44%21.86%14.31%52.51%0.55%54.34%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
16.51%16.51%15.79%15.67%15.41%14.94%
Operating Margin
4.69%4.69%4.65%4.51%4.46%4.16%
Pretax Margin
4.38%4.38%4.24%4.04%3.83%3.55%
Profit Margin
1.50%1.50%1.29%1.57%1.60%1.59%
FCF Margin
6.73%6.73%5.78%5.32%3.91%4.40%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.2250.1940.1350.1540.1420.122
Dividend Per Share Growth
3.04%43.70%-12.34%8.81%15.82%20.94%
Dividend Yield
4.64%5.00%2.67%3.67%2.87%4.96%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
6.776.2210.107.5910.035.92
Forward PE
6.156.577.106.118.755.81
P/FCF Ratio
1.511.392.262.254.112.14
PS Ratio
0.100.090.130.120.160.09